Gregory Moore joined Noramco as a temp one month after retiring from the U.S. Air Force in August 2014. Within a year, he was hired to a permanent position.
Noramco Presents Comments and Answers Questions at FDA Hearing on Cannabidiol
Noramco presented testimony and answered questions at the Food and Drug Administration’s (FDA) Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, Part 15 Public Hearing.
Nemus Bioscience Signs Agreement with Noramco
Nemus Bioscience announced an agreement with Noramco for the manufacturing and scale-up of proprietary analog of cannabidiol (CBD) licensed from the University of Mississippi.
Noramco Adds Capacity and Dual Sources of Supply for Cannabinoids
Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia, United States facility. The expansion comes in response to rising demand for its highly pure cannabidiol (CBD) and dronabinol (THC) analogs of cannabis sativa.
Noramco Announces Provisional Patent Application of Proprietary Cannabidiol (CBD)
Noramco, a global leading producer of controlled substances, including cannabinoids for the pharmaceutical industry, today announced that it has filed a provisional patent application with the US Patent and Trademark Office (USPTO) directed to its proprietary pure cannabidiol (CBD) compositions.
A Winning United Way Campaign
Last fall the Athens site participated in the 2018 United Way Campaign with a goal to pledge $10,000.00 to support 18 agencies in Northeast Georgia…
AXIM Biotechnologies Advances Dronabinol Therapeutic Equivalence Program Through Purchase Agreement With Noramco
AXIM® Biotechnologies, Inc. announced that it has reached a long-term purchase agreement for pharmaceutical-grade dronabinol with Noramco, a global leader in the production of controlled substances for the pharmaceutical industry.
Noramco Competes in 10th Consecutive American Odyssey Relay Run for Charity
Noramco competed in its 10th consecutive American Odyssey Relay run for charity. A team of 12 runners embarked upon a journey from Gettysburg, PA to Washington D.C., spanning 200 miles in a total time of 29 hours and 18 minutes.
Say Hello to Justin Mills
Quality is always evaluating improvements and efficiencies. No one understands that better than Justin Mills, our Quality Systems Supervisor. Joining Noramco 15 years ago, initially as a Quality Control Analyst, he continues to raise the bar in quality.
Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers…